Tag: Biotech
-
Oncosyne at ESMO Targeted Anticancer Therapies Congress 2026 in Paris 🇫🇷
Oncosyne presented new research at ESMO TAT 2026 showing how patient-derived tumoroid models can support predictive biomarker discovery and strengthen decision-making in early oncology drug development. In the poster, Spatial pharmacoproteomics analysis of patient-derived tumoroids from colorectal cancer to identify predictive biomarkers, the team demonstrated how combining functional drug testing with high-content spatial analysis generates deeper…